Press Resease

Global Human Milk Oligosaccharides Market - By Type (3’FL, 2’FL, 3’SL, And 6’SL), By Application (Health Ingredients For Human & Animal, Infant Formulas, Food Supplements, And Food & Beverages), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 12-Jan-2021 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-3837 Status : Published

The global Human Milk Oligosaccharides market value was estimated at 7.69 (USD Billion) in 2019 and is projected to register a CAGR of nearly 15.1% during the period from 2019 to 2025. The market is projected to accrue earnings worth 22.59 (USD Billion) by 2025.

Description

The global Human Milk Oligosaccharides market value was estimated at 7.69 (USD Billion) in 2019 and is projected to register a CAGR of nearly 15.1% during the period from 2019 to 2025. The market is projected to accrue earnings worth 22.59 (USD Billion) by 2025. The report offers valuation and analysis of the Human Milk Oligosaccharides market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).

Introduction

Human milk oligosaccharides are available in breast milk and it finds key application in infant formulas and pharmacology. In addition to this, breast milk offers a balanced nutrient for infant & comprises large proportion of bio-active ingredients including immunoglobulin, oligosaccharides, and hormones. HMOs also referred as human milk oligosaccharides are one of the key component of human milk. Reportedly, these products are structurally & biologically myriad groups of non-digestible sugars having complex structure. The product possesses anti-adhesive features and helps in reducing the infection risk from protozoa, virus, and bacteria.

Market Growth Drivers

The ability of the breast milk in protecting infants from infection along with shielding them from allergic reactions will steer the market size. Apparently, human milk oligosaccharides offers protection to human beings for long-term, namely, against obesity, high blood pressure, auto-immune disorders, diabetes, and heart disorders. Additionally, the compound inhibits sticking of microbes to intestines, proliferation of pathogens & organic acids, and helps in reducing inflammation, thereby driving market trends. The product helps in maintaining gut health through raising the production short-chain fatty acids – a key energy source for enterocytes & main molecule for gut health maintenance.

Apparently, surge in the application of the product in infant formula as well as functional beverages and addition to the product line will prompt the scope of the human milk oligosaccharides market in the years ahead. Growing concerns pertaining to malnourishment in children and rise in the infant mortality rate has culminated in product penetration across the global healthcare sector.

North American Market Size To Expand Manifold Over 2019-2025

The expansion of the human milk oligosaccharides market in the sub-continent over the assessment period is due to massive demand for human donor milk for infants. Reportedly, there are nearly eleven milk banks in the U.S. and Canada. However, these are unable to fulfill the growing demand for breast milk for infants in the sub-continent, thereby steering the market growth in the region. Surge in the consumer awareness pertaining to health benefits of the human milk oligosaccharides for infants will prompt the regional industry growth over the assessment period.

Key participants profiled in the study are Elicityl SA, Inbiose, Medolac Laboratories, ZuChem, Inc., Jennewein Biotechnologie GmbH, Glycom A/S, and Glycosyn LLC.

The global human milk oligosaccharides market is segmented as follows:

By Type

  • 2’FL
  • 3’FL
  • 3’SL
  • 6’SL

By Application

  • Infant formulas
  • Health ingredients for human and animal
  • Food & beverages
  • Food supplements

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Human Milk Oligosaccharides Market , 2015–2025 (USD Billion)
    • 2.2. Human Milk Oligosaccharides Market : Snapshot
  • Chapter 3. Global Human Milk Oligosaccharides Market – Industry Analysis
    • 3.1. Human Milk Oligosaccharides Market : Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. The ability of the breast milk in protecting infants from infection along with shielding them from allergic reactions will steer the market trends.
      • 3.2.2. The product helps in maintaining gut health through raising the production short-chain fatty acids – a key energy source for enterocytes & main mulecule for gut health maintenance, thereby driving market growth.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Application
  • Chapter 4. Global Human Milk Oligosaccharides Market – Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Human Milk Oligosaccharides Market : company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Human Milk Oligosaccharides Market – Application Analysis
    • 5.1. Global Human Milk Oligosaccharides Market overview: By Application
      • 5.1.1. Global Human Milk Oligosaccharides Market share, By Application, 2018 and 2025
    • 5.2. Health Ingredients For Human & Animal
      • 5.2.1. Global Human Milk Oligosaccharides Market By Health Ingredients For Human & Animal, 2015–2025 (USD Billion)
    • 5.3. Infant Formulas
      • 5.3.1. Global Human Milk Oligosaccharides Market By Infant Formulas, 2015–2025 (USD Billion)
    • 5.4. Food Supplements
      • 5.4.1. Global Human Milk Oligosaccharides Market By Food Supplements, 2015–2025 (USD Billion)
    • 5.5. Food & Beverages
      • 5.5.1. Global Human Milk Oligosaccharides Market By Food & Beverages, 2015–2025 (USD Billion)
  • Chapter 6. Global Human Milk Oligosaccharides Market – Type Analysis
    • 6.1. Global Human Milk Oligosaccharides Market overview: By Type
      • 6.1.1. Global Human Milk Oligosaccharides Market share, By Type, 2018 and 2025
    • 6.2. 3’FL
      • 6.2.1. Global Human Milk Oligosaccharides Market By 3’FL, 2015–2025 (USD Billion)
    • 6.3. 2’FL
      • 6.3.1. Global Human Milk Oligosaccharides Market By 2’FL, 2015–2025 (USD Billion)
    • 6.4. 3’SL
      • 6.4.1. Global Human Milk Oligosaccharides Market By 3’SL, 2015–2025 (USD Billion)
    • 6.5. 6’SL
      • 6.5.1. Global Human Milk Oligosaccharides Market By 6’SL, 2015–2025 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Medulac Laboratories
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfulio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Elicityl SA
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfulio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Glycosyn
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfulio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Inbiose
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfulio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Jennewein Biotechnulogie
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfulio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Glycom
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfulio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. ZuChem
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfulio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development

Methodology


Frequently Asked Questions

The ability of the breast milk in protecting infants from infection along with shielding them from allergic reactions will steer the market size. Apparently, human milk oligosaccharides offers protection to human beings for long-term, namely, against obesity, high blood pressure, auto-immune disorders, diabetes, and heart disorders. Additionally, the compound inhibits sticking of microbes to intestines, proliferation of pathogens & organic acids, and helps in reducing inflammation, thereby driving market trends. The product helps in maintaining gut health through raising the production short-chain fatty acids – a key energy source for enterocytes & main molecule for gut health maintenance. Apparently, surge in the application of the product in infant formula as well as functional beverages and addition to the product line will prompt the scope of the human milk oligosaccharides market in the years ahead.

According to Zion market research report, the global Human Milk Oligosaccharides market value was estimated at 7.69 (USD Billion) in 2019 and is projected to register a CAGR of nearly 15.1% during the period from 2019 to 2025. The Human Milk Oligosaccharides market is projected to accrue earnings worth 22.59 (USD Billion) by 2025.

North America is likely to make noteworthy contributions towards overall market revenue during forecast timeframe. The regional market growth over 2019-2025 can be credited to massive demand for human donor milk for infants. Reportedly, there are nearly eleven milk banks in the U.S. and Canada. However, these are unable to fulfill the growing demand for breast milk for infants in the sub-continent, thereby steering the market growth in the region. Surge in the consumer awareness pertaining to health benefits of the human milk oligosaccharides for infants will prompt the regional industry growth over the assessment period.

The key players profiled in the report include Elicityl SA, Inbiose, Medolac Laboratories, ZuChem, Inc., Jennewein Biotechnologie GmbH, Glycom A/S, and Glycosyn LLC.
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com